Letters
Blanket hepatitis B vaccination is questionable in India
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7547.976 (Published 20 April 2006) Cite this as: BMJ 2006;332:976- Peter R Mansfield, director (peter.mansfield@adelaide.edu.au),
- Anant Phadke,
- Ashok Kale
- Healthy Skepticism, Willunga, SA 5041, Australia
EDITOR—We agree with Banatvala et al that adequate economic analysis of universal hepatitis B vaccination is required before recommending policy change in Britain.1 In India plans for universal hepatitis B vaccination have been announced without an economic comparison with other programmes that may be more cost effective.
The marginal cost-efficacy of hepatitis B vaccine in India has been estimated, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.